53 yrs male
post BSO
Diagnosed metatstatic CRPC
progressed on abiraterone , docetaxel , cabazetaxel
started on enza since aug 21 added Lu-PSMA therapy since Sept 21 (received 3 sessions)
Progression on PSMA scan, 2/3 new bone sites, PSA 22.7 (Aug 21) to 43.3 (Mar 22)
FDG low burden.
started on Tab Honvan 120mg BD with Aspirin 75mg on 21/4/2022
4th 177Lu PSMA therapy 231mCi on 20.04.22 as Ac225 not affordable that time.
Total lu dose : 723 (200,150 150, 231 mCi)
*Current Status:*
PSMA PET/CT - multiple PSMA avid skeletal mets and marrow lesions are noted
-few dorsal vertebral lesions and marrow lesions are newly noted
FDG PET/CT scan - Most of PSMA expressing skeletal lesions show FDG uptake
-new vertebral and marrow lesions also show FDG avidity
-overall progression on both PSMA and FDG scan.
PSA : 41
*Current Plan:*
- 1# of 225Ac therapy with 180-200uCi dose will be preferrable
- if not fesable, can plan one more round of Lu177 or asked to wait for next week for planning in Joint Clinic.
-to continue tab honovan 120 mg BD
Please suggest if anyone has any experience or suggestions ?